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Available online 9 August 2016AbstractPurpose: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy.
Methods: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best
corrected visual acuity (BCVA) 20/30 in the amblyopic eye or a difference of BCVA 2 lines between the two eyes were included. They were
randomly classified into the case and control groups (25 in each). Patching was recommended in both groups, and cases also received I-BiT™.
Cases were asked to play I-BiT™ games through appropriate glasses with conjugate colored filters. Moving and fixed targets were shown to the
amblyopic and non-amblyopic eyes, respectively. Playing games was continued 20 min in each session for 5 days a week within one month (total
time: 6.6 h). Patching was continued for one month more in both groups to evaluate the continuous effect of I-BiT™. BCVA was measured at
baseline, one month after beginning I-BiT™, and one month after cessation of I-BiT™.
Results: BCVA of amblyopic eyes in cases and controls were 0.34 ± 0.14 and 0.33 ± 0.17LogMAR at baseline which improved to 0.17 ± 0.14
and 0.26 ± 0.17 at one month, respectively. The difference was significant in each group (p < 0.001 for cases and p ¼ 0.024 for controls) with
more improvement in the case group (p < 0.001). One month after cessation of I-BiT™, BCVA difference between the two groups was not
statistically significant. There was no case with recurrence of amblyopia.
Conclusion: Based on our results, I-BiT™ seems to be effective in amblyopia therapy accompanied with patching. We recommend comparing I-
BiT™ alone with patching in further studies.
ClinicalTrials.gov Identifier: NCT02740725.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ocular lesion.1e5 According to the literature, amblyopia
prevalence ranges from 0.70% to 5% in different reports.6e9
Authors have found an amblyopia prevalence of 2.30% in
primary school children of Tehran, Iran (2013) with a diag-
nostic criterion of BCVA 20/40.1 Anisometropia and stra-
bismus are the most common causes of amblyopia, and in
some cases, both of them might be observed simultaneously.1
Although patching of the dominant eye is the most effective
known method of amblyopia therapy, it has some limitations,
especially among children with less compliance.10,11 VA
improvement needs a long term patching, and it may even laststing by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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of the child and his/her parents.10 In addition, patching might
disrupt the binocular fusion of the child.12
Interactive Binocular Treatment (I-BiT™) has recently
been introduced as a new method of amblyopia therapy.13 It
works by looking through special glasses with red/green filters
or shutter glasses with enhancing and reducing filters for
amblyopic and non-amblyopic eyes in order to dissociate two
eyes from each other.13 Although shutter glasses induce more
foveal stimulation, they are expensive, and most families
cannot afford them. Implementation of a virtual reality system
by applying anaglyphic (red/green) filters encompasses I-
BiT™ advantages with a lower cost.14 The mechanism is
based on presenting different image conditions to each eye of
the amblyopic child while both eyes are open. In this regard,
moving targets are presented to the amblyopic eye in order to
induce more foveal stimulation, and stable targets are shown to
the non-amblyopic eye.
Rastegarpour presented the theory of the I-BiT™ mecha-
nism in details, but its clinical efficiency for amblyopia
treatment was not evaluated in his study.14
One advantage of the I-BiT™ method is its effectiveness at
older age (>8 years old) due to the I-BiT™ ability to activate
dormant cells of the visual cortex.15 Furthermore, there is no
need to patch the dominant eye during I-BiT™ exercises, so
children are more eager to play with its games. Moreover, the
significant improvement ofVAhas been reported during 6weeks
of I-BiT™ playing,whilevisual improvement by patching needs
at least several months.15 In addition, the condition of playing
could be adjusted by contrast and illumination of images; the
image can be rotated in all directions so that it is possible to
conjugate with the child's pupillary distance and angle of ocular
deviation as well.12,15 The clinical efficacy of I-BiT™ has been
reported by Eastgate et al.12 with VA improvement in 42% of
their cases, and it was effective even in severe amblyopic chil-
dren. Moreover, in small sample case series studies, the
considerable VA improvement has been reported after a short
period of time.13,16 Foss et al. reported the efficacy of I-BiT™ on
more amblyopic cases (n ¼ 75 patients). They compared three
groups: playing I-BiT™ games, non I-BiT™ games, and I-
BiT™ DVD video games, but they did not compare I-BiT™
effectiveness when it is accompanied with patching.17
Our purpose was to compare the effect of combined I-
BiT™ and patch therapy with patching alone in unilateral
amblyopic children.
Methods
In this randomized clinical trial, 50 unilateral amblyopic
children (3e10 years) referring to the tertiary referral center
from December 2014 to September 2015 were studied. The
study was approved by the Ethics Committee of the School of
Medicine, Shahid Beheshti University of Medical Sciences,
Tehran, Iran. An informed consent, which explained the details
of our project, was signed by parents of these children before
any intervention. This study conformed to all local rules and
complied with the principles of the Declaration of Helsinki.All unilateral functional amblyopic children with BCVA
worse than 20/30 (0.30 Logarithm angle of resolution [Log-
MAR]) at least in one eye or a difference of two lines of
Snellen between the two eyes were included in this study and
randomly divided into the case (n ¼ 25) and control (n ¼ 25)
groups. Cases had both patching and I-BiT™ games, while
controls had only conventional patch therapy for one month.
The I-BiT™ was stopped while patching was continued in
both groups for one month longer.
Children with a history of penalization one month prior to
the study, bilateral amblyopia, eccentric fixation, nystagmus,
ocular deviation more than 10 prism diopter (pd), and organic
amblyopia, as well as uncooperative children who could not
play or those with mental and physical disability and systemic
diseases were excluded from our study.RandomisationFor this purpose, we used the permuted-block randomiza-
tion method, with the block length varied between 2 and 6. It
was generated by computer program, and the sequence of
randomization was concealed from investigators.Sample sizeTo have a power of 80% to detect 0.20 LogMAR
difference between the two groups when the standard
deviation of BCVA between them was assumed to be 0.25
LogMAR, a sample size of 25 in each group was
calculated.16Clinical assessmentCycloplegic refraction was measured 30e45 min after
instillation of one drop of Cyclopentolate 1% and Tropicamide
1% with 5 min interval.
BCVA was measured after 48e72 h of cycloplegia using a
Yang Vision Tester instrument (SIFI Diagnostic S.P.A-Via
Castellana, 70/e-31100 T revise-Italy) with the Snellen E-
chart containing 5 letters in each line at a 6-m distance and
daylight conditions. It was recorded based on each letter which
equates to 0.025 LogMAR units.17
Ocular alignment was evaluated with alternative prism
cover test (BCVA 20/200) or Krimsky method (BCVA < 20/
200) for both far (6 m) and near (33 cm) distances. In addition,
the function of extraocular muscles was assessed through
duction and version movements by the scale of 4 to þ4
grades. Furthermore, eccentric fixation was evaluated by
monocular visoscopic examination.
Finally, the anterior and posterior ocular segments were
evaluated by slit lamp and indirect ophthalmoscope (HEINE
BETA 200; US) in order to diagnose pathologic lesions.DefinitionsCycloplegic spherical equivalent (SE) 0.50 diopters
(D), þ2.00D, and cylindrical power 0.75D were
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tively. As a rule, 4 h of patching per day was recommended for
moderate amblyopia defined as BCVA of 20/40 to 20/100.18,19
Therefore, 1 h patching per day was ordered for each line
difference of BCVA between the two eyes.Designing of I-BiT™ systemThe software was designed according to the known strategy
in which the dominant eye sees the fixed target, but the
amblyopic eye follows the moving object through the conju-
gate colored filters, including red (Wrattens25) and green
(Wrattens58), that are positioned in the glasses in order to
dissociate the eyes of each subject. In children with corrective
glasses, the filters were set on their glasses.
In the present study, I-BiT™ system was designed in the
format of different known games including Pac-Man, Snake,
and Tetris for their quick learning in both red and green for-
mats corresponding to the colored filter against the amblyopic
eye (Fig. 1). We asked children to play with all of these games
to hold their interest in each session. In addition, to attract
more attention, sound stimuli were added to the games. All
games were designed by the Dot Net Framework version 2.0
Package (Microsoft, Redmond, Washington). This application
runs on the Windows 7 or higher operating system without the
requirement of any third party software, so its installation is
simplified on any personal computer at home.
At the first session, the games were explained to the child
who was asked to play at the clinic under supervision of a
skilled Optometrist, and parents were taught how to install the
software. Then CD games and one redegreen glasses match-
ing with the child's amblyopic eye were given to them.Fig. 1. Schematic views (red/green) of I-BiT™The child was asked to play I-BiT™ games binocularly for
30 min a day, 5 days a week for one month (a total time of
10 h). Younger children who were not able to play games by
mouse were suggested to use the keyboard instead of the
mouse to play easier and improve the hand-eye coordination.
If the child could pass each level successfully, the difficulty of
games was increased, making the amblyopic eye follow the
moving targets with higher speed. Due to controlling the
adherence of children to the daily patching or I-BiT™ playing,
we asked their parents to supervise them and record their time.
In addition, the cooperation of the children was checked by
calling their parents every week.Periodic follow-upsThe BCVA measurement was repeated at the both follow-
ups of 1 month at the end of I-BiT™ treatment and one
month after cessation of its playing. Patching therapy was
continued in both groups (Fig. 2) in order to evaluate whether
I-BiT™ effects will continue or not. At last, the BCVA was
compared with its initial value in each group and between the
two groups as well.Statistical analysisTo assess the normal distribution of data, Kolmogor-
oveSmirnov test and QeQ plot were used. To present data,
we used mean, standard deviation, median and range, fre-
quency, and percent. To compare the baseline characteristics
of participants, we used T-test, ManneWhitney test, Chi-
Square, and Fisher Exact Test. To assess the improvement
within the groups, we used Linear Mixed Model (LMM) andgames. A. Pac-Man; B. Tetris; C. Snake.
Fig. 2. The flowchart of our study. BCVA: Best Corrected Visual Acuity; n: number.
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evaluate the difference between the groups, we adjusted for the
baseline values, and we used Analysis of Covariance
(ANCOVA). All statistical analysis was performed by SPSS
(IBM Corp. Released 2013. IBM SPSS Statistics for Windows,
Version 22.0. Armonk, NY: IBM Corp.). p-value less than 0.05
was considered statistically significant.
Results
In this study, 50 unilateral amblyopic children with a mean
age of 5.67 ± 1.88 years (range: 3e10) with equal numbers of
males and females were included.
Demographic and baseline ocular characteristics of our
patients are presented in Table 1. As shown, there was not any
statistically significant difference between the case and control
groups regarding all considered characteristics except their
ages, which were statistically higher in our case group
(p < 0.001).
As Table 2 and Fig. 3 show, in the case group, there was a
significant improvement of BCVA one month after I-
BiT™ þ patching therapy (p < 0.001); however, the vision
remained unchanged after cessation of the I-BiT™ therapy
with no further improvement. In addition, the BCVA was
improved continuously and gradually in the control group after
the first (p ¼ 0.024) and second months of patching
(p < 0.001). Furthermore, in comparison between the two
groups, improvement of BCVA was higher in cases after one
month of treatment (p < 0.001), whereas there was not asignificant difference of BCVA between the two groups at the
end of the second month of treatment (p ¼ 0.246).
Discussion
I-BiT™ is a type of virtual reality-based system which has
recently been applied as the promising solution for amblyopia
treatment without conventional treatments' limitations such as
occlusion or penalization.14
For many years, patching of the non-amblyopic eye has
been considered a gold standard method in amblyopia treat-
ment,10 so we were not ethically allowed to eliminate occlu-
sion in our cases. Therefore, our cases received I-BiT™ as a
complementary treatment to occlusion, unlike the previous
studies which compared I-BiT™ with occlusion in separate
groups.12,13,15e17
In our study, I-BiT™ was found as an effective comple-
mentary method for amblyopia treatment like other stud-
ies.12,13,15e17 The mean of BCVAwas increased in two groups
significantly with more improvement in cases who received
both I-BiT™ and patching therapy simultaneously. The sig-
nificant improvement of BCVAwas not further increased after
cessation of I-BiT™ in the case group which implies I-BiT's™
effective role in this regard on the one side and lack of its
continuous effect on the other side.
In other related I-BiT™ studies, they did not report the
results of their patients' fusion improvement.12,16
Although the total hours of I-BiT™ treatment for our cases
(6.6 h) was more than other studies (3e4.4 h), the amount of
Table 1
Basic characteristics of children of our study in both groups.
Factors Level Total Groups p
Case (patching þ I-BiT™) Control (patching)
Age (y) Mean ± SD 5.67 ± 1.88 6.28 ± 1.95 5.06 ± 1.62 <0.001a
Median (Range) 5 (3e10) 6 (4e10) 5 (3e10)
Sex Female 25 (50.0%) 14 (56.0%) 11 (44.0%) 0.230c
Male 25 (50.0%) 11 (44.0%) 14 (56.0%)
Ocular alignment Ortho 35 (70.0%) 17 (68.0%) 18 (72.0%) 0.819d
(pd) ET < 10 10 (20.0%) 6 (24.0%) 4 (16.0%)
XT < 10 5 (10.0%) 2 (8.0%) 3 (12.0%)
Baseline BCVA Mean ± SD 0.34 ± 0.15 0.34 ± 0.14 0.33 ± 0.17 0.482b
(LogMAR) Median (Range) 0.3 (0.14e0.78) 0.4 (0.14e0.7) 0.3 (0.14e0.78)
SE (D) Mean ± SD 4.16 ± 2.84 4.09 ± 2 4.23 ± 3.51 0.183a
Median (Range) 4 (3 to 10.5) 3.94 (1e9) 5 (3 to 10.5)
History of patching Yes 16 (50.0%) 11 (44.0%) 5 (71.4%) 0.070d
No 16 (50.0%) 14 (56.0%) 2 (28.6%)
I-BiT™: Interactive Binocular Interaction; y: Year; SD: Standard Deviation; ET: Esotropia; XT: Exotropia; pd: prism diopter; BCVA: Best Corrected Visual
Acuity; LogMAR: Logarithm of the Minimum Angle of Resolution; SE: Spherical Equivalent; D: Diopter; P: Probability.
a Based on independent T-test.
b Based on ManneWhitney test.
c Based on Chi-square test.
d Based on Fisher exact test.
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due to the usage of shutter glasses or younger age of children
in their studies compared to ours.13,16 Waddingham et al. re-
ported an improvement of 10 letters of BCVA after 4.4 h of I-
BiT™ exercises.16
Both groups had similar ocular and demographic charac-
teristics, except in their ages. Our cases showed older ages
compared to our controls (p < 0.001). In spite of this, theyTable 2
Best corrected visual acuity values in three time points of our study.
Time Total
Baseline Value 0.34 ± 0.15
One month after I-BiT™,
(second visit)
Value 0.22 ± 0.16
Change of the 2nd visit
from baseline
0.12 ± 0.1
p-valuea
One month after cessation
of I-BiT™, (third visit, two
months after baseline visit)
Value 0.17 ± 0.17
Change of the third visit
compared to baseline
0.16 ± 0.11
p-valuea
Change of the third visit
compared to second visit
0.04 ± 0.0
p-valuea
I-BiT™: Interactive Binocular Treatment; BCVA: Best Corrected Visual Acuity; P
a Based on Linear mixed model, adjusted for multiple comparison based on the
b Adjusted for baseline value, based on Analysis of Covariance.achieved more improvement of BCVA, which implies the
efficacy of I-BiT™ even in older patients, possibly by acti-
vating dormant cells in their brain.15
Unlike other case series which studied the effect of I-BiT™
for all anisometropic, strabismic, and mixed amblyopia,13,16
we only investigated the anisometropic amblyopic children
to eliminate the effect of eye deviation as a cofounding vari-
able on our findings.BCVA pb
Case (patching þ I-BiT™) Control (patching)
0.34 ± 0.14 0.33 ± 0.17 0.482
0.17 ± 0.14 0.26 ± 0.17 <0.001
0.17 ± 0.09 0.06 ± 0.08
<0.001 0.024
0.16 ± 0.15 0.18 ± 0.19 0.246
0.18 ± 0.09 0.14 ± 0.11
<0.001 <0.001
9 0.01 ± 0.07 0.08 ± 0.09
>0.99 0.003
: Probability.
Bonferroni method.
Fig. 3. BCVA of both groups at base line, end, and one month after cessation
of I-BiT™ treatment. BCVA: Best Corrected Visual Acuity; LogMAR: Log-
arithm Minimum Angle of Resolution.
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the outcome of amblyopia therapy using I-BiT™.13,15 We also
followed up all children for one month after cessation of I-
BiT™ to identify the continuous effect of treatment with I-
BiT™.
The study design (randomized clinical trial) is the strength
of our study, whereas lack of masking and short follow-up are
its limitations. The higher age in the cases could also be
considered another limitation. In addition, we could not
investigate the effect of I-BiT™ alone in amblyopia therapy
due to ethical limitations.
In conclusion, based on our results, I-BiT™ has an effec-
tive, although transient, role in amblyopia therapy accompa-
nied with patching. Further studies with a larger sample size
are needed to elucidate the role of I-BiT™ with and without
patch therapy in anisometropic or strabismic amblyopia.
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